Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00457106 · ClinicalTrials.gov registry record · NA
A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks
A NA study, sponsored by Beth Israel Medical Center.
- Completed
- Registry status
- NA
- Development phase
- 90
- Enrollment target
NCT00457106 is a NA study that has completed, run by Beth Israel Medical Center. The registered enrollment target is 90 participants.
The verdict
NCT00457106, a NA study, has completed, sponsored by Beth Israel Medical Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 90 participants
- Enrollment target
Study Summary
This study compares the efficacy of risperidone to that of paroxetine in the treatment of panic attacks in patients with Panic Disorder and with Major Depressive Disorder with Panic attacks and compares the side effect profile of risperidone vs. paroxetine in treatment of panic attacks and compares response rates of risperidone vs. paroxetine in treatment of panic attacks.
Interventions
- DRUG Risperidone
- DRUG Paroxetine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2002-06 |
| Est. Completion | 2003-06 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00457106
The ClinicalTrials.gov registry entry for NCT00457106 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Beth Israel Medical Center, which has 44 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Risperidone is the first listed.
NCT00457106 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00457106 about?
NCT00457106 is a clinical study titled "A Single-Blind Trial of Risperidone vs. Paroxetine for Treatment of Panic Attacks". This study compares the efficacy of risperidone to that of paroxetine in the treatment of panic attacks in patients with Panic Disorder and with Major Depressive Disorder with Panic attacks and compares the side effect profile of risperidone vs. paroxetine in treatment of panic attacks and compares ...
What is the current status of trial NCT00457106?
This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2002-06. Estimated completion is 2003-06.
What interventions are being tested in trial NCT00457106?
The interventions under investigation include: Risperidone (DRUG), Paroxetine (DRUG).
Who is sponsoring clinical trial NCT00457106?
This trial is sponsored by Beth Israel Medical Center, which has 44 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.